RT Journal Article
SR Electronic
T1 Effective Deep Learning Approaches for Predicting COVID-19 Outcomes from Chest Computed Tomography Volumes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.15.20213462
DO 10.1101/2020.10.15.20213462
A1 Trivedi, Anusua
A1 Ortiz, Anthony
A1 Desbiens, Jocelyn
A1 Robinson, Caleb
A1 Blazes, Marian
A1 Gupta, Sunil
A1 Dodhia, Rahul
A1 Bhatraju, Pavan
A1 Liles, W. Conrad
A1 Lee, Aaron
A1 Ferres, Juan M. Lavista
YR 2020
UL http://medrxiv.org/content/early/2020/10/20/2020.10.15.20213462.abstract
AB The rapid evolution of the novel coronavirus SARS-CoV-2 pandemic has resulted in an urgent need for effective clinical tools to reduce transmission and manage severe illness. Numerous teams are quickly developing artificial intelligence approaches to these problems, including using deep learning to predict COVID-19 diagnosis and prognosis from computed tomography (CT) imaging data. In this work, we assess the value of aggregated chest CT data for COVID-19 prognosis compared to clinical metadata alone. We develop a novel patient-level algorithm to aggregate the chest CT volume into a 2D representation that can be easily integrated with clinical metadata to distinguish Novel Coronavirus Pneumonia (COVID-19+) from other cases of viral pneumonia and normal healthy chest CT volumes with state-of-the-art performance. Furthermore, we present a multitask model for joint segmentation of different classes of pulmonary lesions present in COVID-19 infected lungs that can outperform individual segmentation models for each task. We directly compare this multitask segmentation approach to combining feature-agnostic volumetric CT classification feature maps with clinical metadata for predicting mortality. These approaches enable the automated extraction of clinically relevant features from chest CT volumes for risk stratification of COVID-19+ patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWCL was supported by unrestricted research funds to WCL from the Department of Medicine, University of Washington.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data used on this paper is publicly available and anonimyzed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used for this work have been made publictly available by the China National Center for Bioinformation. http://ncov-ai.big.ac.cn/download?lang=en The diagnosis ResNet model used pre-trained weights from Imagenet (http://www.image-net.org/) http://ncov-ai.big.ac.cn/download?lang=en http://www.image-net.org/